Mammoth Biosciences and GSK Collaborate to Develop CRISPR-Based Covid-19 Test
The goal is to develop an accurate, easy-to-use, fully disposable, rapid, handheld test that can be used to detect active SARS-CoV-2 infections.
Read MorePosted by Laurie Bonner | May 28, 2020 | Covid 19, Uncategorized |
The goal is to develop an accurate, easy-to-use, fully disposable, rapid, handheld test that can be used to detect active SARS-CoV-2 infections.
Read MorePosted by Steve Halasey | May 25, 2020 | Uncategorized |
Roche v-Tac enables clinicians to obtain blood gas values via venous sampling, which is simpler, less painful, and less-invasive than arterial sampling.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The new solution is designed to enable laboratories to enter biospecimens into a biobank and rapidly begin conducting covid-19-related testing and research.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
Genalyte currently has the capacity to test 250,000 patients per month; the company is scaling up to test more than 7,500,000 patients per month by September.
Read MorePosted by | May 6, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The goal is to inform the medical community about the existence of immunity to covid-19 in healthcare settings and eventually the population at large.
Read More